Introduction

Human induced pluripotent stem cells (hiPSCs) are promising resources for various types of tissues in regenerative medicine (Takahashi et al, 2007; Yu et al, 2007). To enable cell therapy from hiPSCs, the development of a large-scale manufacturing system is essential because massive cell numbers are required to compose transplantable cells which are enough to rescue the desired physiological function (Chen et al, 2014; Kim & Kino-Oka, 2020; Tannenbaum & Reubinoff, 2022). In general, hiPSCs are believed to possess their scaffold dependency, thus are cultured under adhesion and monolayer culture conditions (Hayashi & Furue, 2016; Xu et al, 2001). However, utilizing suspension culture without microcarriers or special materials allows for massive production, automation, cost-effectiveness, and safety assurance in industrialized regenerative medicine.

Several attempts have been made to develop suspension culture technologies enabling rapid and large-scale preparation of hiPSCs (Amit et al, 2010; Amit et al, 2011; Dang et al, 2004; Elanzew et al, 2015; Horiguchi & Sakai, 2016; Hunt et al, 2014; Ibuki et al, 2019; Kehoe et al, 2010; Kim et al, 2019; Krawetz et al, 2010; Kwok et al, 2018; Lam et al, 2016; Nath et al, 2017; Oh et al, 2009; Olmer et al, 2012; Rohani et al, 2020; Shafa et al, 2012; Singh et al, 2010; Steiner et al, 2010; Wang et al, 2013; Zweigerdt et al, 2011) (Summarized in Table 1). These studies have achieved long-term culture and/or mass expansion of hiPSCs and/or human embryonic stem cells (hESCs) in suspension conditions. However, completed processes from clonal hiPSC generation to mass production of hiPSCs based on the precise control of cell status have not yet been achieved.

Table 1.

In this study, we have investigated what hampers the stable maintenance of undifferentiated cell states in suspension conditions. HiPSCs cultured in suspension conditions with continuous agitation without any microcarriers or extracellular matrix (ECM) components were more prone to spontaneous differentiation than those cultured in conventional adherent conditions. From screening of candidate molecules to suppress the spontaneous differentiation of hiPSCs, we have identified that inhibitors of PKCβ and Wnt signaling pathways suppress their differentiation into ectoderm and mesendoderm, respectively. In these conditions, we aimed to complete the processes of handling hiPSCs including the generation of hiPSCs with the expansion of bulk population and single-cell sorted clones, long-term culture with robust self-renewal characteristics, single-cell cloning, direct cryopreservation from suspension culture and their successful recovery, and efficient mass production of a clinical-grade hiPSC line.

Results

Suspension cultured hiPSCs are prone to spontaneous differentiation

First, we investigated whether the quality of hiPSCs in suspension and adherent conditions are equivalent or not. HiPSCs cultured in a conventional medium with continuous agitation (90 rpm) in non-adhesive cell culture plates for 2 passages (5 days during passages) were examined (Figure 1A). In suspension culture on day 5 and 10, hiPSCs formed round cell assemblies with slightly uneven surfaces (Figure 1B). Gene expression analysis with RT-qPCR revealed that the expression of differentiation markers, such as PAX6 (ectoderm), SOX17 (endoderm), and T (mesoderm) increased in suspension-cultured hiPSCs for 10 days (Figure 1C). To monitor the spontaneous differentiation at single cell resolution, we established knock-in reporter hiPSC lines of PAX6-tdTomato and SOX17-tdTomato to visualize and quantify the expression of PAX6 and SOX17 at protein level, respectively (Figure 1—figure supplement 1A–H). tdTomato-positive cells were clearly observed in day 10 samples in suspension-cultured hiPSCs, whereas no positive cells were observed in adherent culture conditions (Figure. 1D). Flow cytometric analysis revealed that hiPSCs in suspension-culture conditions contained non-negligible percentages of PAX6-tdTomato-positive and SOX17-tdTomato-positive cells (Figure. 1E and 1F). Western blot analysis revealed that protein expression of PAX6 and SOX17 in suspension-culture was significantly increased (Figure 2—figure supplement 1A–D). The ratio of positive cells for a cell surface marker for undifferentiated hiPSCs, TRA1-60, was significantly lower in suspension-culture conditions (Figure 2—figure supplement 1E and F). These results suggest that a portion of hiPSCs was spontaneously differentiated in suspension conditions when cultured in conventional medium. To examine global changes in gene expression patterns between suspension and adherent conditions, whole-transcriptomic RNA-seq experiments with statistical tests were performed. Gene Set Enrichment Analysis (GSEA) of all the genes and Gene Ontology Enrichment Analysis (GOEA) on differentially-regulated genes revealed that, in suspension conditions, number of genes involved in differentiation toward various tissues and cell-cell adhesions were significantly up-regulated, whereas genes involved in nucleotide metabolism, hypoxic responses, and extracellular matrix organization were significantly-down-regulated (Figure 1G–J). These results suggest that hiPSCs in suspension conditions are in the process of spontaneous differentiation into various cell lineages and are characterized with specific signatures of gene expression patterns.

Figure. 1.

Wnt signaling inhibitors suppress spontaneous mesendodermal differentiation in suspension culture condition

We next investigated the factors having an inhibitory effect on hiPSCs spontaneous differentiation in suspension conditions (Figure 2A). Since Wnt signaling induces the differentiation of human pluripotent stem cells into mesendoderm lineages (Nakanishi et al, 2009; Sumi et al, 2008; Tran et al, 2009; Vijayaragavan et al, 2009; Woll et al, 2008), and is endogenously involved in the regulation of mesendoderm differentiation of pluripotent stem cells (Dziedzicka et al, 2021), we hypothesized that adding Wnt signaling inhibitors/activator may alter spontaneous differentiation of hiPSCs into mesendoderm. Therefore, Wnt signaling inhibitors, IWP2 or IWR-1-endo (Chen et al, 2009), or an activator, CHIR99021 (Ring et al, 2003), were added to the culture medium under suspension conditions. HiPSC aggregates treated with and without inhibitors showed similar shapes (Figure 2B). In contrast, hiPSC aggregates treated with CHIR99021 formed heterogeneously shaped cyst-like structures, suggesting that they were largely differentiated. In samples treated with inhibitors, both T and SOX17 expression levels were significantly reduced to the level of adherent-cultured hiPSCs; however, there was no reduction in PAX6 expression (Figure 2C). In contrast, CHIR99021-treated cell aggregates showed markedly decreased OCT4 and increased T and SOX17 expression. Additionally, SOX17 protein expression was suppressed in hiPSCs treated with IWR-1-endo in suspension-culture conditions, although its expression increased in hiPSCs in suspension conditions with conventional culture medium compared to adherent conditions (Figure 2—figure supplement 1A and B). These results indicate that Wnt signaling inhibitors effectively suppressed mesendodermal differentiation in suspension-culture, but was insufficient to suppress ectodermal differentiation.

Figure 2.

PKC signal inhibitors suppress spontaneous neuroectododermal differentiation in suspension conditions

To identify molecules with inhibitory activity on neuroectodermal differentiation, hiPSCs were treated with candidate molecules in suspension conditions. Out of the candidate molecules tested (listed in Supplementary Table 1), Go6983, a pan-PKC inhibitor (Gschwendt et al, 1996), showed the strongest inhibition against PAX6 expression (Figure 2D). Further, simultaneous treatment with Go6983 and IWR-1-endo decreased PAX6, T, and SOX17 expression, while maintaining OCT4 expression. To confirm these screening test results, the dose dependent effect of Go6983 or another PKCα, β, γ inhibitor GF109203X (GFX) (Toullec et al, 1991) on the inhibition of PAX6 expression was observed at constant concentration of IWR-1-endo (Figure 2E and F). These results demonstrated that the inhibition of PKC signaling pathway effectively suppress neuroectoderm differentiation in hiPSCs cultured in suspension conditions. Furthermore, we tested various PKC inhibitors to suppress neuroectodermal differentiation from hiPSCs in suspension culture using the 201B7 hiPSC line (Figure 2—figure supplement 2A). The suppression of PAX6 expression in hiPSCs cultured in suspension conditions was observed with PKC inhibitors, enzastaurin (Ly317615), sotrastaurin (AEB071), Ro-32-0432, Go6983, GF109203X, and LY333531, which possessed PKCβ inhibition activity (Figure 2—figure supplement 2B-D); however, sotrastaurin and Ro-32-0432 also showed growth inhibition. Thus, for the rest of the study, a PKCβ specific inhibitor, LY333531 (Jirousek et al, 1996) was used. As compared to controls, another hiPSC line, WTc11, cultured in suspension conditions treated with IWR-1-endo and LY333531 formed homogenous, round, smooth-surfaced aggregates (Figure. 3A). PAX6 expression was strongly suppressed by the addition of LY333531 (Figure. 3B). Furthermore, after adding IWR-1-endo, the inhibitory effect of PAX6 expression was further enhanced, and simultaneously, OCT4 expression was restored to the same level as in the adherent-culture. PAX6 protein expression was also suppressed in hiPSCs treated with IWR-1-endo and LY333531 in suspension-culture conditions while its expression increased in suspension conditions with conventional culture medium compared to adherent-conditions (Figure 2—figure supplement 1C and D). The ratio of TRA-1-60-positive cells was higher in suspension-culture conditions supplemented with IWR-1-endo and LY333531 than in control conditions without these inhibitors (Figure 2—figure supplement 1E and F). These results indicate that the maintenance of suspension-cultured hiPSCs is specifically facilitated by the combination of PKCβ and Wnt signaling inhibition.

Figure 3.

We examined the effect of PKCβ and Wnt inhibitors on global gene expression of hiPSCs under suspension conditions. RNA-seq data were obtained from suspension conditions in absence of inhibitors (Sus), supplemented with IWR-1-endo (IWR), LY333531 (LY), IWR-1-endo and LY333531 (IWRLY), and adherent conditions (Ad). Hierarchical clustering obtained from these data showed that LY and IWRLY were grouped closely with Ad (Figure 3C). In contrast, Sus and IWR were both grouped as discrete populations from Ad. Additionally, hierarchical clustering in gene expression among these conditions was supported by principal component 1 (PC1) in the principal component analysis (PCA) (Figure 3D). In contrast, PC2 represented genes related to the effects of specific inhibitors under these conditions. Next, we investigated the effect of LY333531 and IWR-1-endo in suspension culture. Many genes involved in pluripotency: KLF4 and ID1, and epithelial cell-cell interactions: CDH1 (E-cadherin), were significantly up-regulated in IWRLY, while many transcription factors involved in differentiation: PAX2, 3, 5, and 8, SP5, DBX1, and TFAP2B, were down-regulated in IWRLY (Figure 3E). GSEA and GOEA on down-regulated genes in IWRLY showed that the expression of developmentally associated genes, whose expression was elevated in Sus, was generally reduced in IWRLY (Figure 3F and G). GOEA on up-regulated genes revealed gene sets involved in epithelial cell types (Figure 3H). As compared to Ad, genes involved in sensory system development, cell-cell adhesion, and Wnt and PI3K signaling pathways were up-regulated in IWRLY, and genes involved in nucleotide metabolism and hypoxic responses were down-regulated under IWRLY conditions (Figure 3—figure supplement 1A-D). These results suggest that PKCβ and Wnt signaling inhibitors in suspension conditions regulate global gene expression patterns to suppress spontaneous differentiation, albeit remaining expression signatures of suspension culture, possibly due to the microenvironment within the formed aggregates and physiological differences.

Further, we examined the expression pattern changes in specific isoforms of PKCs in hiPSCs cultured in adherent/suspension conditions. RNA expression of PKCα (PRKCA) and PKCβ (PRKCB) was significantly up-regulated under suspension-culture conditions compared to adhesion conditions (Figure 3—figure supplement 2A). Moreover, phospho-PKCβ protein expression was significantly elevated (Figure 3—figure supplement 2B and C). These results suggest that elevated expression of PKCβ in suspension-cultured hiPSCs could affect the spontaneous differentiation.

Simultaneous inhibition of PKCβ and Wnt signals maintains undifferentiated hiPSCs in suspension for long-term culture

We next performed long-term culture for 10 passages in suspension conditions and compared hiPSC growth in presence of LY333531 or Go6983. When hiPSCs were seeded at 4 × 10⁵ cells/well, the average cell number reached approximately 12-fold after 5 days under both conditions (Figure 4A and B). After 10 passages, aggregates of hiPSCs cultured in the presence of LY333531 showed a uniform spherical shape, whereas aggregates cultured in the presence of Go6983 were heterogeneously spherical (Figure 4C). Notably, in LY333531-treated cells, OCT4-positive cell numbers were significantly higher than in Go6983-treated samples, as determined by immunostaining (Figure 4D and E). To evaluate whether hiPSCs cultured in suspension conditions with PKCβ and Wnt signaling inhibitors for 10 passages maintain pluripotency, we performed embryoid body (EB) formation assay. These EBs contained positive cells for TUJ1, SMA, and AFP as ectodermal, mesodermal, and endodermal marker, respectively (Figure 4F). Comparative genomic hybridization (CGH) array analysis showed that hiPSCs cultured long-term in the presence of PKCβ and Wnt inhibitors retained their normal human karyotype (Figure 4G). These results indicate that, for long-term culture, inhibition of Wnt signaling and PKCβ in suspension conditions was sufficient to maintain the self-renewal, pluripotency, and genomic integrity of hiPSCs.

Figure 4.

We further investigated whether the effects of PKCβ and Wnt inhibitors on suppressing hiPSCs spontaneous differentiation in suspension-culture conditions are applicable to other culture medium. Morphologies and gene expression profile of hiPSCs, cultured in suspension conditions with another commercially available maintenance medium, StemScale (ThermoFisher Scientific, Inc., MA, USA), were examined (Figure 4—figure supplement 1A). HiPSCs cultured in suspension treated with IWR-1-endo and LY333531 formed homogenously round and smooth-surfaced aggregates compared to controls (Figure 4—figure supplement 1B). The differentiation markers expression, which was elevated under suspension conditions, was suppressed by the simultaneous addition of PKCβ and Wnt signal inhibitors, as observed with StemFit medium (Figure 4—figure supplement 1C and D). These results suggest that conventional suspension culture methods might contain spontaneous differentiating cells and that the addition of inhibitors of PKCβ and Wnt signaling pathways to culture medium generally suppresses spontaneous differentiation.

Mass and clonal expansion of hiPSCs in suspension conditions supplemented with inhibitors of PKCβ and Wnt signaling pathways

For the clinical applications of hiPSCs, its homogenous mass production is required to obtain sufficient quantities. To test the feasibility of mass production under suspension-culture conditions supplemented with PKCβ and Wnt signal inhibitors, we first performed suspension-culture using healthy-donor derived hiPSC lines, 1383D6 and 1231A3, in a 30 mL bioreactor with stirring blade and demonstrated that undifferentiated hiPSCs were efficiently maintained in this condition (Figure 5—figure supplement 1A). These cell lines showed higher cell density in the bioreactor at each passage after 3 days (Figure 5—figure supplement 1B). Under these conditions, the concentration of glucose decreased daily (Figure 5—figure supplement 1C), whereas that of L-lactic acid increased (Figure 5—figure supplement 1D). These results indicate that the cell lines proliferated with active energy consumption. Further, RT-qPCR analysis showed no marked differences in the undifferentiated and differentiation markers expression between hiPSCs cultured in adhesion vs. suspension with PKCβ and Wnt inhibitors (Figure 5—figure supplement 1E and F). Flow cytometric analysis showed that more than 90% of these cells were positive for pluripotency marker proteins: NANOG, OCT4, and SOX2 (Figure 5—figure supplement 1G). G-band analysis of suspension-cultured hiPSCs after five passages revealed normal karyotype (Figure 5—figure supplement 1H). These results demonstrate that undifferentiated hiPSCs were efficiently maintained in the bioreactor using the culture medium supplemented with inhibitors of PKCβ and Wnt signaling pathways.

Next, we expanded hiPSCs in a large-scale culture system under perfusion conditions in the presence of IWR-1-endo and LY333531. In this experiment, clinical-grade hiPSC line, Ff-l14s04, which is derived from PBMCs of a donor carrying homozygous alleles for major HLA loci (HLA-A, HLA-B, and HLA-DR) was used (Kitano et al, 2022). Large-scale hiPSCs preparation using a perfusion-culture system with 320 mL bioreactor having stirred-wing was performed in GMP-compliant, clinical grade StemFit AK03N medium containing IWR-1-endo and LY333531 (Figure 5A). When the culture was started at 1 × 10⁵ cells/mL in 320 mL medium, hiPSCs proliferated nearly 10-fold after 3 to 4 days and reached approximately 1 × 10⁹ cells in total to produce ~300 stock vials (1 × 10⁶ cells/vial). This large-scale culture was repeated three times (Passages 1, 2, and 3), and hiPSCs obtained at each passage were characterized. These samples showed similar or higher viability (>90%) to that of adherent-culture derived cells (Figure 5B). When compared to adherent conditions, these samples in suspension-culture showed a similar or higher proliferation rate (Figure 5C). Cells obtained from large-suspension cultures formed typical hiPSC-like colonies, after vials were thawed and seeded in adherent-culture conditions (Figure 5D). Flow cytometry detected over 90% of cells positive for pluripotent cell markers expression: TRA-1-60, SSEA4, and OCT4 (Figure 5E and F). Further, G-band analysis revealed that hiPSCs retained their normal karyotype even after three passages under large-scale suspension conditions (Figure 5G). When large-scale suspension-culture derived hiPSCs were incubated in each germ layer-specific differentiation medium for 4 - 7 days, the expression of early differentiation markers for ectoderm (PAX6 and SOX1), mesoderm (T and PDGFRA) and endoderm (SOX17 and CXCR4) was significantly induced (Figure 5H). These cells were then directly differentiated into dopaminergic neural progenitors, cardiomyocytes, and hepatocytes to evaluate their differentiation capacity and propensity. There were no differences in the differentiation efficiency toward these lineages (Figure 5I-M). Hence, these results indicate that the characteristics and quality of clinical-grade hiPSCs cultured in large-scale suspension conditions in the presence of PKCβ and Wnt inhibitors were equivalent to those of hiPSCs maintained under adherent conditions. Taken together, we were successful in mass suspension-culture conditions supplemented with Wnt and PKCβ inhibitors.

Figure 5.

Single cell sorting and expansion of hiPSC subclones cultured in suspension conditions

We sorted a hiPSC line, 201B7, with TRA-1-60 antibody into individual wells of a 96-well plate and attempted to establish subclones by expanding them with serial passages (Figure 6A). By day 28 after this single-cell sorting, we expanded single-cell-sorted hiPSC subclones in suspension culture supplemented with IWR1-endo and LY3333531 (Figure 6B). On day 28, we examined seven subclones for their cell growth and expression of OCT4 and TRA-1-60. The subclones showed more than three million cells and high ratios of OCT4- and TRA1-60-positive cells (Figure 6C-E). These results indicate that we have successfully derived single-cell-cloned sublines in suspension culture.

Figure 6.

Direct freeze and thaw of hiPSCs cultured in suspension conditions

We froze a hiPSC line, 201B7, in suspension culture conditions supplemented with IWR1-endo and LY3333531. Then, we thawed these frozen vials and directly reseeded the cells in suspension conditions (Figure 6—figure supplement 1A). By day 10 after reseeding, we expanded the hiPSCs in suspension culture supplemented with IWR1-endo and LY3333531 (Figure 6—figure supplement 1B). On day 10, we examined three vials for their cell growth and expression of OCT4 and TRA-1-60. The subclones showed more than three million cells and high ratios of OCT4- and TRA1-60-positive cells (Figure 6—figure supplement 1C-E). These results indicate that we have successfully frozen and thawed hiPSCs in suspension culture directly.

Together, these results suggest that the suspension culture conditions supplemented with Wnt and PKCβ inhibitors are robust in harsh conditions such as single-cell expansion and freezing-and-thaw processes.

Establishment of hiPSC lines in complete suspension-culture conditions supplemented with inhibitors of PKCβ and Wnt signaling pathways

For the clinical use of hiPSCs, more secure and efficient establishment of hiPSCs in closed systems is strongly desired. To achieve this, we aimed to establish hiPSCs in suspension-culture conditions. Using PBMCs as a starting material, we generated hiPSCs using a novel replication-defective and persistent Sendai virus vector (SeVdp) infection or episomal vector electroporation, as these methods are well-known for producing transgene-free, clinical-grade hiPSCs (Fusaki et al, 2009; Nishimura et al, 2011) (Figure 7A). PMBCs were infected with SeVdp carrying OCT4, SOX2, KLF4, and L-MYC. Infected cells were kept cultured by repeating passages every 5 - 6 days. Cell aggregates cultured with IWR1-endo and LY33351 showed uniform spherical structure (Figure 7B), and most of the cells were positive for OCT4 (Figure 7C) and TRA-1-60 (Figure 7D) on day 56. These bulk cells were able to differentiate into three germ layers in an in vitro EB formation assay (Figure 7E) and in teratomas that were transplanted into immunodeficient NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) mice (Figure 7F). These bulk-hiPSCs maintained normal karyotype (Figure 7G). By single cell sorting with fluorescent labeled TRA-1-60 antibody, we expanded single-cell-derived clones in suspension-culture conditions. A clone (F-10) showed OCT4 and TRA1-60 expressions (Figure 7H-J). In addition, the established clone showed potency to differentiate into derivatives of three germ layers in vitro as EBs (Figure 7K) and in vivo as teratoma transplanted into NSG mice (Figure. 7L). A normal karyotype was observed in this clone (Figure 7M). SeVdp was nearly extinct in these bulk populations and F-10 clone (Figure 7N). These results demonstrate that, we were successful in establishing transgene-free hiPSC lines using SeVdp infection in suspension-culture conditions in the presence of PKCβ and Wnt inhibitors.

Figure 7.

Furthermore, we were successful in establishing single-cell-derived hiPSC lines using the transfection of episomal plasmid vectors in suspension-culture conditions in the presence of PKCβ and Wnt signaling inhibitors. PMBCs were transfected with episomal plasmid vector mix carrying OCT4, SOX2, KLF4, L-MYC, LIN28, and mp53DD and cultured in suspension conditions in the presence or absence of IWR-1-endo and LY33351 with repeated passages to reach enough cell numbers to make cell stocks and characterization (Figure 7—figure supplement 1A). After 36 days of culture, 59% double positive cells for TRA-1-60 and SSEA4 were observed in control, whereas 78% were seen in the presence of IWR-1-endo and LY333531 (Figure 7—figure supplement 1B and C). We performed cell sorting of TRA-1-60 and SSEA4 double positive cells and further repeated 5 more passages in the absence or presence of IWR-1-endo and LY333531. Cell aggregates cultured in culture medium supplemented with IWR-1-endo and LY333531 showed uniform spherical structures (Figure 7—figure supplement 1D), and the most of these cells were TRA-1-60 and SSEA4 double positive (Figure 7—figure supplement 1E). In contrast, cell aggregates cultured without these inhibitors showed lumpy, heterogeneous shapes, and decreased undifferentiated population. Immunostaining of OCT4 on dissociated cell aggregates resulted in higher OCT4 positive cells in IWR-1-endo and LY333531 treated cells (Figure 7—figure supplement 1F and G). We further performed single cell sorting of TRA-1-60-positive cells from bulk-cultured populations at 10 passages (Figure 7—figure supplement 1H and I). We selected 3 clones to be characterized further. These clones showed round spherical shapes in their aggregates and expression of OCT4, NANOG, and TRA-1-60 proteins (Figure 7—figure supplement 1J-L). Pluripotency into three germ layers was confirmed in vitro with EB formation assay (Figure 7—figure supplement 1M) and teratoma formation analysis (Figure. Figure 7—figure supplement 1N). These clones retained a normal karyotype even after a long-culture (Figure 7—figure supplement 1O). These results demonstrate that single-cell-derived hiPSC lines were established using the transfection of episomal plasmid vectors in suspension-culture conditions in the presence of PKCβ and Wnt signaling inhibitors.

Discussion

In this study, we have developed a series of methods to generate and maintain hiPSCs in suspension conditions. First, we have identified compounds that suppress spontaneous differentiation of hiPSCs in suspension cultures. Based on these findings, we have newly achieved a complete series of culture processes including hiPSC establishment, long-term culture, mass culture, single-cell cloning, and direct freeze and thaw (summarized in Table 1). These methods require no special materials including microcarriers or dialysis bags, and are effective with various existing culture media and many hiPSC lines. Therefore, this suspension-culture of hiPSCs is anticipated to have novel industrial applications, which have been never achieved with conventional methods because suspension-culture conditions, which precisely control cellular states, have advantages in terms of mass culture, automation, and safety assurance.

We have identified two compounds as factors that ameliorate the disadvantages of the suspension culture of hiPSCs. Wnt signaling inhibitors specifically inhibited differentiation toward mesendoderm, whereas, the PKCβ inhibitor, LY333531, inhibited ectodermal differentiation and, when combined with IWR-1-endo, maintained the undifferentiated nature of hiPSCs with high efficiency. Go6983, a pan-PKC inhibitor, has been used to promote the self-renewal of mammalian PSCs (Dutta et al, 2011; Kinehara et al, 2013; Rajendran et al, 2013; Takashima et al, 2014); however, in these cases, the role of specific isoforms in PSC self-renewal and differentiation are not fully elucidated yet. In this study, we demonstrated that PKCβ-specific inhibitor LY333531 as well as Go6983 showed the suppression of neuroectodermal differentiation. Interestingly, these combinations of chemical inhibitors against WNT and PKC signaling pathways are also being used in the induction and maintenance of naive human pluripotent stem cells (Bayerl et al, 2021; Bredenkamp et al, 2019; Guo et al, 2017; Khan et al, 2021). While, in suspension-culture, we did not aim to drive hiPSCs to a naïve state by the use of these combinations of chemical inhibitors conditions, it would be worthwhile to investigate the effect of adaptation of suspension-culture supplemented with PKCβ and Wnt signaling inhibitors on the transition of the naïve PSCs types.

We successfully generated hiPSC lines from PBMCs in suspension conditions for the first time by adding the abovementioned compounds to the culture medium. Both transduction methods with SeVdp and episomal plasmid vectors enabled the establishment of hiPSCs under suspension conditions in the presence of IWR-1-endo and LY333531. Clonal expansion of hiPSCs was also performed by single-cell sorting with flow cytometry and were successfully characterized for their self-renewal, pluripotency, and genomic integrity. These results indicate that hiPSC lines generated in suspension conditions have the same quality in terms of their pluripotency, self-renewal, and genomic integrity as those generated with conventional adherent conditions. Precise control of hiPSC status in suspension culture could pave the way for their stable and automated clinical application toward autologous cell therapy of hiPSCs.

Methods

Human subjects

The generation and use of hiPSCs were approved by the Ethics Committee of RIKEN BioResource Research Center, Graduate School of Medicine of Kyoto University, and KANEKA CORPORATION.

Animal experiments

All animal experiments were approved by the Animal Experimentation Committee of the RIKEN Tsukuba branch and were performed according to the committee’s guiding principles and the “Guide for the Care and Use of Laboratory Animals” published by the National Institute of Health.

Data availability

All data are available in the main text or the supplementary materials. RNA-seq data are available in the Gene Expression Omnibus as GSE222833. All the data supporting the findings of this study are available from the lead contact upon reasonable request. Source data is provided with this paper. This paper does not report original code.

HiPSCs cultured in adherent conditions

WTC11 (GM25256 from Coriell Institute) (Hayashi et al, 2016), 201B7 (HPS0063 from RIKEN Cell Bank) (Takahashi et al., 2007), 454E2 (HPS0077 from RIKEN Cell Bank) (Okita et al, 2011), 1383D6 (HPS1006 from RIKEN Cell Bank) (Okita et al., 2011), 1231A3 (HPS0381 from RIKEN Cell Bank) (Okita et al., 2011), and Ff-I14s04 (CiRA foundation, Kyoto University) (Kitano et al., 2022) were used as healthy-donor hiPSC lines. With tdTomato-reporter hiPSC lines, we generated knock-in hiPSC lines for PAX6-TEZ (constructed from 454E2 line) and SOX17-TEZ (constructed from 1383D6 line) using CRISPR-Cas9 genome editing (Tsukamoto et al, 2021) (Figure. S1A). These hiPSCs were cultured in StemFit AK02N medium (Cat#AK02N, Ajinomoto, Co., Ltd., Tokyo, Japan). Medium change was performed every day and passaged at 80%–90% confluency after 6-7 days of culture. At passage, PBS/EDTA solution (0.5 mM, Cat#06894-14, Nacalai Tesque) was used to dissociate hiPSC colonies, and these cells were seeded at a density of 2,500 cells/cm². 10 µM Y-27632 (Cat#HY-10071, FUJIFILM Wako Pure Chemical Corporation, Osaka, Japan) and 0.25 µg/cm² iMatrix-511 silk (Cat#892021, Matrixome Inc, Osaka, Japan) were added to the culture dish on seeding day.

Suspension-culture of hiPSCs

Suspension culture with rotation at 90 rpm was performed with a plate shaker (Cat#WB-101SRC, WAKENBTECH, Kyoto, Japan or #0081704-000, TAITEC, Tokyo, Japan) installed in a CO₂ incubator (Cat#Steri-Cycle i160, Thermo Fisher Scientific, MA, USA) and operated under high humidity continuously during the whole culture period. To start the culture hiPSCs in suspension conditions, 4 × 10⁵ cells were seeded in one well of a low-attachment 6-well plate (Cat#MS-80060, Sumitomo Bakelite, Tokyo, Japan) with 4 mL of StemFit AK02N medium, StemFitAK03N (Cat#AK03N, Ajinomoto, Co., Ltd., Tokyo, Japan), or StemScale PSC suspension medium (A4965001, Thermo Fisher Scientific, MA, USA) supplemented with 10 µM Y-27632. This plate was placed onto the plate shaker in the CO₂ incubator. The medium without Y-27632 was changed every day unless otherwise specified. On days 3 - 5, the hiPSC aggregates were dissociated with Accutase (Cat#12679-54, Nacalai Tesque) at 37°C for 10 min and used for the next suspension-culture. This passage was performed every 5 days unless otherwise specified. To screen for factors that inhibit spontaneous differentiation of hiPSCs, chemicals or recombinant proteins were added to the culture medium (listed in Supplementary Table S1).

Bioreactor culture of hiPSCs

A frozen stock of hiPSCs was pre-cultured twice in adherent conditions to prepare enough cell numbers. To prepare enough hiPSCs to start large-scale culture, hiPSCs were pre-cultured in iMatrix-511MG (Cat#892 005, Matrixome, Inc, Osaka, Japan) or Vitronectin (VTN-N) Recombinant Human Protein, Truncated (Cat#A14700, Thermo Fisher Scientific, MA, USA)-coated cell culture flasks with StemFit AK03N medium including 20 µM IWR-1-endo and 1 µM LY333531. Perfusion-culture was started with 3.2 - 4.8 × 10⁷ cells in 320 mL of StemFit AK03N medium (Cat#AK03N, Ajinomoto, Tokyo, Japan) with IWR-1-endo and LY333531. The reactor system BioFlo320 (Eppendorf, Hamburg, Germany) was used for large-scale hiPSCs culture. To maintain the lactate concentration below a certain level and to regulate the pH, the culture was carried out by increasing the amount of medium perfusion per unit time in accordance with the cell proliferation transition. To prevent pH decrease, CO₂ concentration was regulated by feedback control in the reactor system. After 3-4 days of culture, the formed hiPSC aggregates were dissociated with TrypLE SELECT (Cat#A12859-01, Thermo Fisher Scientific, MA, USA) collected for making cell stocks (~300 tubes). This perfusion culture was repeated three times (P1, P2, and P3) and the cells were prepared at each expansion step.

HiPSC generation in suspension culture conditions

HiPSCs were generated from healthy donor-derived PBMCs (Precision for Medicine). Thawed PMBCs from a vial containing around 1 × 10⁷ cells were pre-cultured in one well of low attachment 6-well plate including 4 mL of StemSpan-AOF (Cat#ST100-0130, STEMCELL Technologies, Vancouver, Canada) supplemented with recombinant human IL-6 (100 ng/mL), IL-3 (10 ng/mL), SCF (300 ng/mL), TPO (300 ng/mL), and FLT3 ligand (300 ng/mL) (all from FUJIFILM Wako Pure Chemical Corporation, Tokyo Japan). After 24 h of incubation with continuous stirring at 37°C and 5% CO₂, PBMCs were spun down with centrifugation at 200 × g for 10 min at low deceleration speed and resuspended in StemSpan ACF for cell counting. 2.5 × 10⁶ cells of PMBCs were centrifuged at 200 × g for 10 min with low deceleration speed, and electroporated using Nucleofector 2b device (Lonza, Basel, Switzerland) with iPS cell Generation Episomal vector Mix (Takara Bio, Shiga, Japan) and Amaxa Human CD34⁺ Cell Nucleofector kit (Lonza, Basel, Switzerland) according to manufacturer’s protocol. 5 × 10⁵ of electroporated cells were seeded in one well of a low attachment 6-well plate in 4 mL StemSpan ACF with the cytokines mentioned above. Suspension-culture was performed with continuous agitation at 90 rpm. Stem span ACF medium were gradually replaced with StemFit AK02N medium. Formed cell aggregates were passaged with Accutase on day 16 in the presence of 10 µM Y27632, and suspension-culture was continued until the cell numbers reached a sufficient amount for characterization. 10 µM IWR-1-endo and 1 µM LY333531 were added from day 3.

SeVdp infection was performed with Sendai Reprogramming Kit (CytoTune EX-iPS of virus solution, ID Pharma, Tsukuba, Japan) according to the manufacturer’s protocol with some modifications. Briefly, pre-cultured 1 × 10⁶ PMBCs were centrifuged at 200 × g for 10 min, with low deceleration speed, and resuspended in 2 mL of StemSpan ACF with cytokines. PMBCs were gently mixed with 2 mL of virus solution prepared at MOI = 5 per 1 × 10⁶ cells. 5 × 10⁵ infected cells were seeded in one well of low-attachment 6-well plate at a total volume of 4 mL with StemSpan ACF plus cytokines. Suspension-culture was initiated with continuous agitation at 90 rpm. Stem span ACFs were gradually replaced with StemFit AK02N as mentioned above, and the cell aggregates were passaged with Accutase on day 16 in the presence of 10 µM Y-27632. Suspension-culture and passages continued until cell reached a sufficient number for characterization. 10 µM IWR-1-endo and 1 µM LY333531 were added from day 23.

Three germ layer differentiation in vitro

For Embryoid body (EB) formation assay, suspension-cultured hiPSC lines were dissociated with Accutase and 1.0 x 10⁴ cells were seeded in each well of an EZ-BindShut 96-well-V plate (Cat#4420-800SP AGC TECHNO GLASS CO., LTD, Shizuoka, Japan) with 100 µL Stem Fit AK02N medium supplemented with 10 µM Y-27632. Before culture, the 96-well-V plate was centrifuged at 200 x g for 3 min for efficient cell mass formation. The next day, the culture medium was switched to DMEM high Glucose (Cat#08458-16, Nacalai tesque, Kyoto, Japan) supplemented with 10% fetal bovine serum (here after referred as EB medium). On day 8, EBs were transferred into 0.1% (w/v) Gelatin Solution (Cat#190–15805, FUJIFILM Wako Pure Chemical Corporation, Tokyo Japan)-coated 12-well plate and further cultured in EB medium for another 8 days. The medium was changed every day. EBs were fixed with 4% paraformaldehyde in Dulbecco’s Phosphate Buffered Saline (D-PBS) (Cat#14249-24, Nacalai tesque, Kyoto, Japan) for 10 min at room temperature and used for immunostaining. Differentiation was validated by immunostaining against each germ layer markers.

The differentiation potency of suspension-cultured hiPSCs toward three germ layers was also evaluated by culturing in germ layer specific differentiation medium. For ectodermal differentiation, suspension-cultured hiPSCs spheroids were cultured with Stem Fit AK02N without C medium supplemented with 10 µM SB431542 (Cat#198-16543, FUJIFILM Wako Pure Chemical Corporation, Tokyo, Japan) and 10 µM DMH1 (Cat#041-33881FUJIFILM Wako Pure Chemical Corporation, Tokyo, Japan) for 7 days. For mesodermal differentiation, suspension-cultured hiPSCs spheroids were cultured with RPMI1640 medium (FUJIFILM Wako Pure Chemical Corporation, Tokyo, Japan) supplemented with B-27 supplement, minus insulin (A1895601, Thermo Fisher Scientific, MO, USA) and 7.5 µM CHIR99021 (Cat#034-23103, FUJIFILM Wako Pure Chemical Corporation, Tokyo, Japan) for 1 day, and continuously with RPMI1640 medium supplemented with B-27 supplement for 2 days. For endodermal differentiation, suspension-cultured hiPSCs spheroids were cultured with RPMI1640 medium supplemented with 1 mM Sodium pyruvate (FUJIFILM Wako Pure Chemical Corporation, Tokyo, Japan), 1 x NEAA (FUJIFILM Wako Pure Chemical Corporation, Tokyo, Japan), 80 ng/mL Activin A (R&D Systems, MN, USA), 55 µM 2-mercaptethanol (FUJIFILM Wako Pure Chemical Corporation, Tokyo, Japan), 50 ng/mL FGF2 (R&D Systems, MN, USA), 20 ng/mL BMP4, and 3 µM CHIR99021 for 2 days, and continuously with RPMI1640 medium supplemented with 1 mM Sodium pyruvate, 1× NEAA, 80 ng/mL Activin A, 55 µM 2-mercaptethanol, and 0.5% Knockout serum replacement (KSR; Thermo Fisher Scientific, MO, USA) for 2 days.

Neuroectoderm and endoderm differentiation of reporter hiPSC lines

Reporter hiPSC lines, PAX6-TEZ and SOX17-TEZ were used as positive controls for in vitro neuroectoderm and endoderm differentiation, respectively. PAX6-TEZ was seeded in each well of a 24 well-plate coated with 0.25 µg/cm² iMatrix-511 silk with 1 mL StemFit AK02N medium supplemented with 10 µM Y-27632. Next day, the culture medium was switched to Stem Fit AK02N medium without supplement C, instead of containing 10 µM SB431542 and 10 µM DMH1. SOX17-TEZ was seeded in each well of a 24 well-plate (same as above), and on the next day, the culture medium was switched to StemFit AK02N medium without supplement C instead of containing 3 µM CHIR99021 and 10 ng/mL Activin A (Cat#014-23961, FUJIFILM Wako Pure Chemical Corporation, Tokyo, Japan). The medium was changed every day. On day 7, tdTomato expression was observed under all-in-one fluorescent microscope (BZ-X800; KEYENCE).

Cardiomyocyte differentiation

Cardiomyocyte differentiation was performed according to a modified method described previously (Funakoshi et al, 2016). Both large-scale suspension cultured hiPSCs and typical adherent-cultured hiPSC were collected by centrifugation after dissociation into single cell with TrypLE Select. The cells were suspended in 1.5 mL cardiomyocyte differentiation media (CDM), consisting of StemPro34 medium (Thermo Fisher Scientific) supplemented with 2 mM Glutamax (Thermo Fisher Scientific), 50 μg/mL ascorbic acid, 4 × 10^-4 M monothioglycerol (Sigma-Aldrich), 150 μg/mL transferrin (Roche), and with Matrigel (Cat#354277, Corning, NY, USA)), 10 μM Y-27632 and 2 ng/mL human recombinant BMP4 (R&D Systems) and then cultured in ultra-low attachment 6 well plate (Corning) in 5%CO₂/5% O₂. After 24 h, 1.5 mL CDM with 6 ng/mL human recombinant activin A (R&D Systems) and 5 ng/mL bFGF (R&D Systems) were added into the wells. After 3 days, medium was changed to 3 mL CDM with 10 ng/mL VEGF (R&D Systems), SB431542 (Sigma-Aldrich), Dorsomorphin (Sigma-Aldrich) and 1 µM IWP-3 (Stemgent). After 7 days, medium was changed to 3 mL CDM with 10 ng/mL VEGF (R&D Systems). The medium was changed every 2 days. The cells were collected at 15 days after differentiation and analyzed by flow cytometry.

Dopaminergic progenitor cells differentiation

Dopaminergic progenitor cells differentiation was performed according to a modified method described previously (Doi et al, 2020). Both large-scale suspension cultured hiPSCs and typical adherent-cultured hiPSC were collected by centrifugation after dissociation into single cell with TrypLE Select. The cells were suspended in 1 mL dopaminergic progenitor cells differentiation medium-1 (DPM-1), consisting of Glasgow’s minimum essential medium (Thermo Fisher) supplemented with 8% knockout serum replacement (Thermo Fisher Scientific), 1% MEM Non-Essential Amino Acids Solution (Thermo Fisher Scientific), 1 mM sodium pyruvate (Sigma-Aldrich), 0.1 mM 2-mercaptoethanol (FujiFilm Wako) and 100 nM LDN193189 (Stemgent), and were then seeded in iMatrix-coated 24-well plates at a density of 1 × 10⁶ cells/well with 10 µM Y-27632 and 500 nM A-83-01 (FujiFilm Wako). After 1 and 2 days, medium was changed to DPM-1 with 500 nM A-83-01, 100 ng/mL recombinant human FGF8 (FujiFilm Wako), and 2 μM purmorphamine (FujiFilm Wako). After 3 to 6 days, medium was changed every day to DPM-1 with 500 nM A-83-01, 100 ng/mL recombinant human FGF8, 2 μM purmorphamine, and 3 μM CHIR99021 (FujiFilm Wako). After 7 to 11 days, medium was changed every day to DPM-1 with 3 μM CHIR99021. On differentiation day 12, cells were dissociated using TrypLE select and suspended in the dopaminergic progenitor cells differentiation medium-2 (DPM-2), consisting Neurobasal medium (Thermo Fisher Scientific), 2% B27 supplement (without Vitamin A, Thermo Fisher), 1% GlutaMAX (Thermo Fisher Scientific), 10 ng /mL human recombinant glial cell-derived neurotrophic factor (FujiFilm Wako), 200 mM ascorbic acid, 20 ng / mL human recombinant brain-derived neurotrophic factor (FujiFilm Wako), and 400 μM dibutyryl cAMP (FujiFilm Wako), and were then plated on U-shaped 96-well plates (Thermo Fisher Scientific) at a density of 2 × 10⁴ cells/150 µL/well with 10 µM Y-27632. After 15 to 26 days, half of medium was changed every 2 days to DPM-2. Dopaminergic progenitor cells differentiation efficiency was analyzed by flow cytometry at 12 days after differentiation. On differentiation day 12, cells were labeled with anti-CORIN antibody (Clone 5B6, Sigma-Aldrich) and secondary antibody (A11001, Thermo Fisher).

Hepatocyte differentiation

Hepatocyte differentiation was performed according to a modified method described previously (Si-Tayeb et al, 2010). Both large-scale suspension-cultured and typical adherent-cultured hiPSCs were collected by centrifugation after dissociation into single cell with TrypLE Select. These hiPSCs were cultured on Matrigel-coated 6-well plates until 80% confluency with StemFit medium (Ajinomoto). To initiate differentiation, the medium was changed to 1 mL Hepatocyte differentiation medium (HDM) consisting of RPMI1640 medium (Thermo Fisher) supplemented with 1× GlutaMax (Thermo Fisher) and 1× B27 Supplement minus vitamin A, with the addition of 100 ng/mL Activin A (R&D Systems). After 1 to 3 days, medium was changed every day to HDM with 100 ng/mL Activin A. After 4 to 8 days, medium was changed every day to HDM with 20 ng/mL human recombinant BMP-4 (R&D Systems) and 20 ng/mL human recombinant FGF-4 (R&D Systems). After 9 to 13 days, medium was changed every day to HDM with 20 ng/mL human recombinant HGF (R&D Systems). After 14 to 24 days, medium was changed every 2 days to Hepatocyte Culture Medium (HCM; Lonza) with 20 ng/mL human recombinant Oncostatin M (R&D Systems). On differentiation day 25, the albumin concentration in the culture supernatant was determined by ELISA using an anti-human albumin antibody (Betyl Laboratories, Catalog # E88-129).

Teratoma formation

Suspension-cultured hiPSCs were dissociated with Accutase and then resuspended with 1 mL of StemFit AK02N medium supplemented with 10 µM Y-27632. 1 x 10⁶ cells were collected by centrifugation at 200 × g for 3 m and suspended in ice-cold 50% Matrigel solution: StemFit AK02N with 10 µM Y-27632 = 1:1). Cells were injected into testis or leg of NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) mice (The Jackson Laboratory, Bar Harbor, ME, USA) using an 18-G needle. Two to three months later, teratomas were collected and fixed with 4% paraformaldehyde in D-PBS. Paraffin-embedded sectioning and hematoxylin-eosin (HE) staining was performed. Three germ layer derivatives were observed under CKX53 microscope with a DP22 camera and CellSens software (EVIDENT, Tokyo, Japan).

Karyotyping

For virtual karyotyping, genomic DNA (gDNA) was extracted from hiPSCs using a DNeasy Blood & Tissue Kit (Cat#69504, QIAGEN, Hulsterweg, Netherland) and was used for microarray assay. Virtual karyotyping was performed with GeneChip Scanner System 3000 using Karyostat Assay arrays (Cat#905403, both from Thermo Fisher Scientific, MA, US) according to the manufacturer’s protocol. Data were analyzed using the Chromosome Analysis Suite (ChAS) and Affymetrix GeneChip Command Console software programs.

G-band analysis was performed using the common Giemsa staining method with hiPSCs fixed by Carnoy’s fixtative (3:1 ratio of methanol: glacial acetic acid).

qRT-PCR

Total RNA was extracted with a FastGene RNA premium kit (Cat#FG-81250, NIPPON Genetics, Tokyo, Japan) and used for reverse transcription reaction. cDNA was synthesized by using a ReverTra Ace qPCR RT kit (Cat#FSQ-101, TOYOBO, Osaka, Japan) with random primers. Real-Time qPCR reactions were performed with a QuantStudio 3 System (Thermo Fisher Scientific) using THUNDERBIRD Probe qPCR Mix (Cat#QPS-101, TOYOBO) with TaqMan probes (listed in Supplementary Table 2) (Thermo Fisher Scientific) according to the manufacturer’s instructions. Gene expression was described as the fold change relative to the control sample value (ΔΔCt method) after normalization to the corresponding GAPDH or β-Actin values, unless otherwise specified. For the residual SeV detection, data were normalized to the expression of GAPDH and displayed as relative fold increase to hiPSC line established with episomal vector (WTc11). SeVdp-infected fibroblasts on passage 1 (SeV-34 and -39) were used as positive controls.

Immunocytochemistry

Immunocytochemistry was performed on adherent cells. Suspension-cultured hiPSCs were dissociated with Accutase and transiently cultured as adherent in iMatrix-coated culture dishes for 3 h before immunocytochemistry. The cells were fixed with 4% paraformaldehyde in D-PBS for 10 min at room temperature, then permeabilized in D-PBS containing 0.1% Triton X-100 for another 10 min. Cells were incubated with primary antibodies in D-PBS containing 0.1% Bovine Serum Albumin (BSA; Cat#017-22231, FUJIFILM Wako Pure Chemical Corporation, Tokyo, Japan) overnight at 4 °C. The secondary antibodies were incubated for 1 hour at room temperature in D-PBS containing 0.1% BSA. Fluoro-KEEPER Antifade Reagent, Non-Hardening Type with DAPI (Cat#12745-74, Nacalai tesque, Kyoto, Japan) was used for nuclear counterstaining. Fluorescence images were taken with an all-in-one fluorescent microscope (BZ-X800; KEYENCE, Osaka, Japan). The primary and secondary antibodies used in this study are listed in Supplementary Tables 3 and 4, respectively.

Automatic capillary Western blot (Simple Western Assays)

To detect the expression of PAX6 or SOX17, adherent- or suspension-cultured PAX6-TEZ or SOX17-TEZ hiPSCs were collected on day 10 (Passage 2). The cell lysate was prepared from 1 × 10⁶ cells with sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer solution without 2-ME (2x) (Cat#30567-12, Nacalai Tesque) supplemented with 100 mM Dithiothreitol (DTT) (Cat#14130-41, Nacalai Tesque). To detect phosphorylated PKCβ, cell lysates were collected on day 5 of suspension-cultured hiPSCs with extraction buffer mentioned above, containing 1% phosphatase inhibitor cocktail (Cat#07574-61, Nacalai Tesque). Samples were denatured at 95°C for 5 min. Western blotting was performed with a capillary automatic western blotting device (Simple Western, Wes; Bio-Techne, CA, USA). Jes/Wes 12- to 230-kDa separation module for Wes, 8 × 25 capillary cartridges (Cat#SM-W004, ProteinSimple), and Anti-Rabbit/Goat/Mouse Detection Module kit (Cat#DM-002/DM-001/DM/006, ProteinSimple) were used. Preparation of reagents and sample loading were conducted according to the manufacturer’s instructions. The data were analyzed and quantified by compass for simple Western software program (ProteinSimple). GAPDH was used as the reference for normalization. The primary antibodies used in this study are listed in Supplementary Table 3.

Flow cytometry

Flow cytometry of self-renewal markers, TRA-1-60 and SSEA4 was performed as described in our previous study. Briefly, adherent- or suspension-cultured hiPSCs were dissociated with 0.5 mM EDTA solution in D-PBS or Accutase, respectively. Dissociated cells (0.5 or 1 × 10⁶ cells) were collected and centrifuged at 200 × g for 3 minutes and resuspended in 500 or 1000 µL PBS containing 0.1% BSA and 0.5 mM EDTA, then incubated with or without anti-TRA-60 antibody or anti-SSEA4 antibody for 1 hour at 4 °C under oblique light conditions. After washing with PBS, cells were resuspended in 500 mL D-PBS containing 0.1% BSA and 0.5 mM EDTA, and filtrated with 35-mm cell strainer (Cat#352235, FALCON, Thermo Fisher Scientific). For PAX6-TEZ and SOX17-TEZ hiPSC lines, adherent- or suspension-cultured hiPSCs were dissociated into single cells and collected cells were resuspended in 500 mL PBS containing 0.1% BSA and 0.5 mM EDTA. After passing through the 35-mm cell strainer, cells were analyzed for tdTomato. The primary and secondary antibodies used in this study are listed in Supplementary Table 3 and 4, respectively. Flow cytometry was performed with SH800 cell Sorter (SONY, Tokyo, Japan).

RNA-Seq

Total RNA was extracted using the FastGene RNA premium kit, and strand-specific library preparation was performed. The prepared library was sequenced using a NovaSeq6000 (Illumina, Inc, CA, USA). Sequencing was performed in a 150 bp × 2 paired-end conFigureuration with a data output of about 6 Gb per sample (~ 20 million paired reads). Library preparation and sequencing was performed in GENEWIZ (Azenta, MA, USA). To identify differentially regulated genes, sequencing data was analyzed with a CLC Genomics Workbench (QIAGEN, Hulsterweg, the Neterlands) and R package, edgeR (v3.30.3) in R language (v 4.1.0). An MA plot (log2 fold change versus mean average expression) comparing transcriptomes between suspension- and adherent-culture from RNA-seq data. Transcripts with log2 fold change ≧ 2 or ≦ −2 (FDR <0.01) are highlighted with red and blue dots, respectively. The extracted genes were analyzed for gene ontology enrichment and biological pathways using the R package, clusterProfiler (v3.16.1). GSEA was also performed using clusterProfiler. An enrichment map was used to visualize the GSEA results with enrichment score (ES) and false discovery rate (FDR) values. Software used for the analysis is listed in Supplementary Table 5.

Statistical analysis

Statistical analysis was performed using Student’s t-test or Dunnett’s test for multiple comparisons with a single control condition. P values < 0.05 were considered statistically significant. *, ** or *** in the graphs indicate P<0.05, P<0.01 or P<0.001, respectively. No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment.

Acknowledgements

We thank Dr. Bruce Conklin for providing us with the WTC11 hiPSC line; Dr. Shinya Yamanaka, Dr. Kazutoshi Takahashi, Dr. Masato Nakagawa, and Dr. Keisuke Okita for providing us with 201B7, 454E2, 1231A3, 1383D6, and Ff-I14s04 hiPSC lines. We would like to express our sincere gratitude to Dr. Kaoru Saijo, Mr. Daiki Kondo and Mr. Masahiko Yamada for their technical assistance, and Ms. Kumiko Omori for her administrative support. This work was funded by a collaborative research grant from Kaneka corporation. We would like to thank Editage [http://www.editage.com] for editing and reviewing this manuscript for English language.

Author Contributions

Conceptualization: YHA, Methodology: MMT, SK, CW, KT,MI, YHA, Investigation: MMT, SK, YHE, TW, TS, YA, KT, MI, MN, MU, TMK, MN, KN, YN, YHA, Visualization: MMT, SK, TS, YH, Funding acquisition: MMT, TN, YK, YHA, Project administration: MMT, TN, YK, YHA, Supervision: MMT, TN, YN, NT, YK, YHA, Writing – original draft: MMT, KS, MT, YHA, Writing – review & editing: MMT, YHA

Competing Interest Statement

Y. HA received collaborative research grant from KANEKA corporation during this study. S. K., K.T., M. I., Y.K., and T.N. were employed with KANEKA corporation during this study. M.M.T., S.K. K.T., M. I., Y.K., and Y.HA. are inventors of patents arising from this work (WO/2021/162090 and PCT/JP2020/005255). The other authors declare no competing interests.

Classification

Applied Biological Sciences, Cell Biology, and Developmental Biology in BIOLOGICAL SCIENCES

Figures and Tables

Figure 1—figure supplement 1.

Figure 2—figure supplement 1.

Figure 2—figure supplement 2.

Figure 3—figure supplement 1.

Figure 3—figure supplement 2.

Figure 4—figure supplement 1.

Figure 5—figure supplement 1.

Figure 6—figure supplement 1.

Figure 7—figure supplement 1.

Supplementary Table 1.

Supplementary Table 2.

Supplementary Table 3.

Supplementary Table 4.

Supplementary Table 5.